Gmt Capital Corp Rocket Pharmaceuticals, Inc. Transaction History
Gmt Capital Corp
- $2.49 Billion
- Q1 2024
A detailed history of Gmt Capital Corp transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Gmt Capital Corp holds 230,000 shares of RCKT stock, worth $4.95 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
230,000
Previous 306,500
24.96%
Holding current value
$4.95 Million
Previous $9.19 Million
32.54%
% of portfolio
0.25%
Previous 0.35%
Shares
7 transactions
Others Institutions Holding RCKT
# of Institutions
205Shares Held
92.9MCall Options Held
341KPut Options Held
107K-
Rtw Investments, LP New York, NY17.7MShares$381 Million7.65% of portfolio
-
Wellington Management Group LLP Boston, MA9.16MShares$197 Million0.04% of portfolio
-
Black Rock Inc. New York, NY5.93MShares$128 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.37MShares$116 Million0.0% of portfolio
-
State Street Corp Boston, MA4.19MShares$90.3 Million0.01% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $1.63B
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...